NautilusTM ECMO Oxygenator with Balance Biosurface-used in extracorporeal life support procedures to oxygenate blood, remove carbon dioxide and regulate blood temperature. Product Number: (1) 48145; (2) 48145E
Publicado el 27 de marzo de 2024 · Inicio del retiro: 11 de octubre de 2023
Resumen
FDA registra el retiro Z-1309-2024 de dispositivos médicos de Clase II, publicado el 27 de marzo de 2024 e iniciado el 11 de octubre de 2023. Empresa responsable: Mc3 Inc; Estado: En curso; Cantidad reportada: 299 units; Lote: GTIN: (1) 10854916006888; (2) 10854916006901,20854916006908 (New GTIN (USA only)After reboxing). All Serial Numbers between 481022923 and 481024039. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
May have increased water path restriction within the heat exchanger, leading to degraded heat exchange performance during use. The reduction of water flow and reduced heat exchange performance may be experienced immediately upon priming or may worsen over the duration of use. The potential harm as stated in the IFU includes hypothermia due to inadequate heat transfer
Qué hacer
Voluntary: Firm initiated · E-Mail
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Mc3 Inc
- Distribuidor
- US Nationwide distribution.
- Lote
- GTIN: (1) 10854916006888; (2) 10854916006901,20854916006908 (New GTIN (USA only)After reboxing). All Serial Numbers between 481022923 and 481024039
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDANautilusTM Smart ECMO Module with Balance Biosurface-used in extracorporeal life support procedures to27 de marzo de 2024
- FDACuraplex Nasal Intubation Kit w/ 7mm Endotracheal Tube-To perform a nasal intubation to establish an airway in27 de marzo de 2024
- FDACuraplex Nasal Intubation Kit with 6mm Endotrol Tube-To perform a nasal intubation to establish an airway in27 de marzo de 2024
- FDASekisui Diagnostics Control Kit OSOM® BVBLUE® Bacterial Vaginosis27 de marzo de 2024
- FDAnatus neurology, Sleep Supplies Start Kit with Single Use Supplies for Embla EX Series Amplifiers, REF 02425227 de marzo de 2024
- FDAAbbott Rapid Dx N America LLC Reproductive Endocrinology Control Set McKesson Consult" Pregnancy (hCG) Testing27 de marzo de 2024
Preguntas sobre este retiro
¿NautilusTM ECMO Oxygenator with Balance Biosurface-used in extracorporeal life support procedures to oxygenate blood, remove carbon dioxide and regulate blood temperature. Product Number: (1) 48145; (2) 48145E fue retirado del mercado?
Sí. FDA publicó el retiro Z-1309-2024 el 27 de marzo de 2024. Peligro reportado: May have increased water path restriction within the heat exchanger, leading to degraded heat exchange performance during use. The reduction of water flow and reduced heat exchange performance may be experienced immediately upon priming or may worsen over the duration of use. The potential harm as stated in the IFU includes hypothermia due to inadequate heat transfer
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · E-Mail